Xbrane Reveals Ranibizumab Refiling Plans For US

FDA Said Additional Information Was Needed To Accept Lucentis Rival BLA For Review

 
• By David Wallace
  
More Info Button
More information on the filing was requested by the FDA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products